New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017

J Am Heart Assoc. 2019 May 21;8(10):e011306. doi: 10.1161/JAHA.118.011306.
No abstract available

Keywords: patient‐reported outcome; pediatrics; pharmacology; research ethics; research method.

Publication types

  • Consensus Development Conference

MeSH terms

  • Age Factors
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Clinical Trials as Topic / methods*
  • Cooperative Behavior
  • Drug Approval*
  • Humans
  • Patient Safety
  • Patient Selection*
  • Patients*
  • Public-Private Sector Partnerships
  • Pulmonary Arterial Hypertension / diagnosis
  • Pulmonary Arterial Hypertension / drug therapy*
  • Pulmonary Arterial Hypertension / physiopathology
  • Research Personnel*
  • Research Subjects*
  • Risk Assessment
  • Risk Factors
  • Stakeholder Participation*
  • Treatment Outcome

Substances

  • Antihypertensive Agents